LLY

1,047.61

-0.13%↓

JNJ

245.73

+0.21%↑

ABBV

227.86

+0.03%↑

NVS

166.32

+0.99%↑

MRK

124.28

+0.66%↑

LLY

1,047.61

-0.13%↓

JNJ

245.73

+0.21%↑

ABBV

227.86

+0.03%↑

NVS

166.32

+0.99%↑

MRK

124.28

+0.66%↑

LLY

1,047.61

-0.13%↓

JNJ

245.73

+0.21%↑

ABBV

227.86

+0.03%↑

NVS

166.32

+0.99%↑

MRK

124.28

+0.66%↑

LLY

1,047.61

-0.13%↓

JNJ

245.73

+0.21%↑

ABBV

227.86

+0.03%↑

NVS

166.32

+0.99%↑

MRK

124.28

+0.66%↑

LLY

1,047.61

-0.13%↓

JNJ

245.73

+0.21%↑

ABBV

227.86

+0.03%↑

NVS

166.32

+0.99%↑

MRK

124.28

+0.66%↑

McKesson Corp

Отворен

СекторЗдравеопазване

954.31 0.6

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

937.96

Максимум

958.31

Ключови измерители

By Trading Economics

Приходи

40M

1.3B

Продажби

3B

106B

P/E

Средно за сектора

26.954

110.024

Дивидентна доходност

0.33

Марж на печалбата

1.177

Служители

43,000

EBITDA

374M

1.8B

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+3.48% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.33%

2.26%

Следващи печалби

7.05.2026 г.

Следваща дата на дивидент

1.04.2026 г.

Следваща дата на екс-дивидент

2.03.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

10B

115B

Предишно отваряне

953.71

Предишно затваряне

954.31

Настроения в новините

By Acuity

35%

65%

101 / 351 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

McKesson Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

23.02.2026 г., 22:53 ч. UTC

Придобивния, сливания и поглъщания

Keurig Dr Pepper Raises Additional $1.5 Billion in Deal to Split Company

23.02.2026 г., 22:36 ч. UTC

Печалби

Kratos Defense & Security Solutions 4Q Profit Rises; Sees Federal Shutdown Denting 1Q -- Update

23.02.2026 г., 22:32 ч. UTC

Печалби

Woodside Energy Fiscal Year Net Profit Falls 24%

23.02.2026 г., 23:58 ч. UTC

Пазарно говорене
Печалби

Plenty of Questions for Woodside Despite Well-Guided Result -- Market Talk

23.02.2026 г., 23:58 ч. UTC

Пазарно говорене
Печалби

Global Energy Roundup: Market Talk

23.02.2026 г., 23:47 ч. UTC

Пазарно говорене

Scentre's Share Price Slips as Earnings Guidance Underwhelms -- Market Talk

23.02.2026 г., 23:43 ч. UTC

Пазарно говорене

Gold Edges Higher Amid Ongoing Tariff Risks -- Market Talk

23.02.2026 г., 23:41 ч. UTC

Придобивния, сливания и поглъщания

Crescent Capital Partners Owns 53% of ClearView Wealth

23.02.2026 г., 23:40 ч. UTC

Придобивния, сливания и поглъщания

ClearView Wealth Says Crescent Capital Partners Intends to Support Deal

23.02.2026 г., 23:40 ч. UTC

Придобивния, сливания и поглъщания

ClearView Wealth Says Directors Unanimously Recommend Shareholders Vote in Favor of Deal

23.02.2026 г., 23:40 ч. UTC

Пазарно говорене

Nikkei May Rise as Investors Assess Tariff Developments -- Market Talk

23.02.2026 г., 23:40 ч. UTC

Придобивния, сливания и поглъщания

ClearView Wealth Says Zurich Insurance Offering A$0.65/Share in Cash

23.02.2026 г., 23:39 ч. UTC

Придобивния, сливания и поглъщания

ClearView Wealth Agrees to Takeover by Zurich Insurance Group Unit

23.02.2026 г., 23:31 ч. UTC

Печалби

United Overseas Bank 2025 Total Dividend S$1.56/Shr >U11.SG

23.02.2026 г., 23:31 ч. UTC

Печалби

United Overseas Bank Proposes Final Dividend of S$0.71/Shr Vs. S$0.92/Shr >U11.SG

23.02.2026 г., 23:28 ч. UTC

Печалби

United Overseas Bank 4Q Net Interest Income S$2.35B Vs. S$2.45B >U11.SG

23.02.2026 г., 23:28 ч. UTC

Печалби

United Overseas Bank 4Q Oper Pft S$1.76B Vs. Pft S$1.88B >U11.SG

23.02.2026 г., 23:28 ч. UTC

Печалби

United Overseas Bank 4Q Total Income S$3.29B Vs. S$3.46B >U11.SG

23.02.2026 г., 23:27 ч. UTC

Печалби

United Overseas Bank 4Q Net S$1.41B Vs. Net S$1.52B >U11.SG

23.02.2026 г., 23:24 ч. UTC

Пазарно говорене

Major Miners On Whole Delivered Positive Earnings Season -- Market Talk

23.02.2026 г., 22:38 ч. UTC

Придобивния, сливания и поглъщания

Keurig Dr Pepper Raises Additional $1.5B in Deal to Split Company

23.02.2026 г., 22:31 ч. UTC

Печалби

Hims & Hers Stock Falls. Why Earnings Are Underwhelming Investors. -- Barrons.com

23.02.2026 г., 22:24 ч. UTC

Печалби

Viva Energy Energy & Infrastructure Ebitda A$93 Million

23.02.2026 г., 22:22 ч. UTC

Печалби

Viva Energy FY Commercial & Industrial Ebitda A$460.5 Million

23.02.2026 г., 22:22 ч. UTC

Печалби

Viva Energy FY Convenience & Mobility Ebitda A$197.4 Million

23.02.2026 г., 22:22 ч. UTC

Печалби

Viva Energy FY Underlying Ebitda A$700.9 Million

23.02.2026 г., 22:22 ч. UTC

Печалби

Viva Energy Final Dividend 3.94 Australian Cents/Security

23.02.2026 г., 22:21 ч. UTC

Печалби

Viva Energy FY Revenue A$28.53 Billion, Down 1.1%

23.02.2026 г., 22:21 ч. UTC

Печалби

Viva Energy FY Replacement-Cost Net Profit A$183.6 Million, Down 28%

23.02.2026 г., 22:20 ч. UTC

Печалби

Viva Energy FY Historical-Cost Net Loss A$421.1 Million

Сравнение с други в отрасъла

Ценова промяна

McKesson Corp Прогноза

Ценова цел

By TipRanks

3.48% нагоре

12-месечна прогноза

Среден 982.27 USD  3.48%

Висок 1,107 USD

Нисък 885 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за McKesson Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

11 ratings

9

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

681.92 / 707.28Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

No Evidence

Дългосрочен план

No Evidence

Настроение

By Acuity

101 / 351 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat